TAIZHOU, Jiangsu, China, April 22 /PRNewswire-Asia/ -- Jiangsu government's China Medical City (CMC) and Shenzhen Beike Biotechnology Co. Ltd. (http://www.beikebiotech.com ) broke ground on the 20,000 square-meter Stem Cell Regenerative Medicine Industrial Project of National Bio-Industry Base (NBPD). This facility will house China's first comprehensive regenerative medicine technology center and its largest international stem cell bank.
The NBPD facility is part of multi-stage project that consists of industry
partnerships aimed at providing a central research zone for China's
regenerative medicine and bio-medical industry. Groups associated with this
biotechnology incubation joint-project include those from
Mr. Chen Zhu, China's Minister of Health, sent a letter of support that was read at April's ground-breaking ceremony. In his letter he stated that biotechnology is China's fastest developing technology, and stem cell research promises to improve the quality of life for people everywhere. The NBPD program was created to improve the understanding of stem cell technology and facilitate China's development as a world leader in the biotechnology industry.
Located in the heart of Taizhou and occupying more than 20 square kilometers, the CMC district enjoys investment privileges as well as full support from the local, provincial and national governments. CMC is quickly becoming a world center for biotechnology due to the geographical concentration of medical services and manufacturing, effectively increasing research efficiency and streamlining production.
|SOURCE Beike Biotech Company Co., Ltd.|
Copyright©2009 PR Newswire.
All rights reserved